TanyaMTrippettMD

Pediatric Hematology & Oncology • New York, NY

Associate Attending Pediatrician

Overview of Dr. Trippett

Dr. Tanya Trippett is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and NYC Health + Hospitals / Bellevue. She received her medical degree from Duke University School of Medicine and has been in practice 32 years. She is one of 92 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She also speaks multiple languages, including French. She has more than 60 publications and over 500 citings.

Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021
Book by Phone+1(913) 534-8125
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1988 - 1991
Duke University HospitalResidency, Pediatrics, 1985 - 1988
Duke University School of MedicineClass of 1985

Certifications & Licensure

NJ State Medical License 2023 - 2025
NY State Medical License 1995 - 2024
NC State Medical License 1987 - 1998
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2014
New York Magazine: Top Doctors Castle Connolly, 2013-2014

Clinical Trials

Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma Start of enrollment: 1995 Aug 01
Completed
Phase 2
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma Start of enrollment: 1996 Jan 01
Completed
Phase 2
Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma Start of enrollment: 1999 Jan 01
Completed
Phase 2
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma Start of enrollment: 2001 May 01
Completed
Phase 2
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation Start of enrollment: 2004 May 01
Terminated
Phase 1
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Start of enrollment: 2004 Sep 01
Completed
Phase 1
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens Start of enrollment: 2006 Jul 01
Terminated
Phase 2
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma Start of enrollment: 2007 Nov 13
Completed
Phase 2
Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II) Start of enrollment: 1994 Mar 01
Completed
Phase 2
Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH Start of enrollment: 1995 Jan 01
Completed
Phase 2
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) Start of enrollment: 1996 Mar 01
Completed
Phase 2
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma Start of enrollment: 1990 May 01
Completed
Phase 2
Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors Start of enrollment: 2008 Oct 01
Completed
Phase 1
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
Completed
Phase 2
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
A Safety Study of SGN-CD19A for Leukemia and Lymphoma Start of enrollment: 2013 Feb 01
Completed
Phase 1
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment Start of enrollment: 2016 Oct 01
Active, not recruiting
Phase 1, Phase 2
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Start of enrollment: 2016 Feb 16
Completed
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

24 citations
Tumour extracellular vesicles and particles induce liver metabolic dysfunction.
Gang Wang, Jianlong Li, Linda Bojmar, Haiyan Chen, Zhong Li, Gabriel C Tobias, Mengying Hu, Edwin A Homan, Serena Lucotti, Fengbo Zhao, Valentina Posada, Peter R Oxley...> ;Nature. 2023 Jun 1
2 citations
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab.
Arash Nabbi, Arnavaz Danesh, Osvaldo Espin-Garcia, Stephanie Pedersen, Johanna Wellum, Lingyan Helen Fu, Joseph N Paulson, Birgit Geoerger, Lynley V Marshall, Tanya Tr...> ;Nature Cancer. 2023 Apr 1
12 citations
Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study.
Tanya Trippett, Helen Toledano, Quentin Campbell Hewson, Arnauld Verschuur, Anne-Marie Langevin, Isabelle Aerts, Lisa Howell, Soledad Gallego, Claudia Rossig, Amy Smit...> ;Targeted Oncology. 2022 May 1
2 citations
Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML.
Kavitha Ramaswamy, Peter G Steinherz, Anurag K Agrawal, Christopher J Forlenza, Audrey Mauguen, Mikhail Roshal, Tanya Trippett, Nancy A Kernan, Maria Luisa Sulis, Shuk...> ;Blood Advances. 2022 Apr 26
Emergency room imaging in pediatric patients with cancer: analysis of the spectrum and frequency of imaging modalities and findings in a tertiary cancer center and the...
Sungmin Woo, Abdallah Araji, Mohammad Ali El Amine, Natalie Gangai, Elizabeth Acquafredda, Anita P. Price, Tanya M. Trippett, Hedvig Hricak, Hebert Alberto Vargas, Ger...> ;Cancer Imaging. 2021 Aug 28
12 citations
Extracellular vesicle and particle isolation from human and murine cell lines, tissues, and bodily fluids.
Linda Bojmar, Han Sang Kim, Gabriel C. Tobias, Fanny A. Pelissier Vatter, Serena Lucotti, Kofi Ennu Gyan, Candia M. Kenific, Zurong Wan, Kyung A. Kim, DooA Kim, Jonath...> ;STAR Protocols. 2021 Mar 19
66 citations
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Nature Cancer. 2021 Feb 15
19 citations
A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center.
Evan Noch, Sameer Farouk Sait, Shama Farooq, Tanya M. Trippett, Alexandra Miller> ;Neuro-Oncology Practice. 2021 Feb 3
15 citations
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma
Karen Wright, Xiaopan Yao, Wendy B. London, Pei Chi Kao, Lia Gore, Stephen P. Hunger, Russ Geyer, Kenneth J. Cohen, Jeffrey C. Allen, Howard M. Katzenstein, Amy Smith,...> ;Pediatric Blood & Cancer. 2021 Feb 1
565 citations
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan M. Hernandez, Constantinos P. Zambirinis, Gonçalo Rodrigues, Henrik Molina, Søren H...> ;Cell. 2020 Aug 20
12 citations
Genetic basis for iMCD-TAFRO
Akihide Yoshimi, Tanya M. Trippett, Nan Zhang, Xueyan Chen, Alexander V Penson, Maria E. Arcila, Janine D. Pichardo, Jeeyeon Baik, Allison Sigler, Hironori Harada, Dav...> ;Oncogene. 2020 Feb 12
13 citations
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
Nirali N. Shah, Deepa Bhojwani, Keith J. August, André Baruchel, Yves Bertrand, Jessica Boklan, Luciano Dalla-Pozza, Robyn M. Dennis, Nobuko Hijiya, Franco Locatelli, ...> ;Pediatric Blood & Cancer. 2020 May 1
83 citations
Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.
Birgit Geoerger, C. Michel Zwaan, Lynley V. Marshall, Jean Michon, Franck Bourdeaut, Michela Casanova, Nadège Corradini, Gianluca Rossato, Mufiza Farid-Kapadia, Colby ...> ;The Lancet. Oncology. 2020 Jan 1
2 citations
Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma
Lucy Swift, Chunfen Zhang, Olga Kovalchuk, Jessica Boklan, Tanya M. Trippett, Aru Narendran> ;Investigational New Drugs. 2020 Jun 1
8 citations
Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma.
Lucy Swift, Chunfen Zhang, Tanya M. Trippett, Aru Narendran> ;Oncotargets and Therapy. 2019 Feb 18
Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.
Aarthi Jayanthan, Bradley Hofmann, Vanessa Meier-Stephenson, Maneka Perinpanayagam, Sandra E. Dunn, Jessica Boklan, Tanya M. Trippett, Tony H. Truong, Aru Narendran> ;Journal of Pediatric Hematology/oncology. 2019 Aug 1
7 citations
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib
Lucy Swift, Aarthi Jayanthan, Yibing Ruan, Ronald Anderson, Jessica Boklan, Tanya M. Trippett, Aru Narendran> ;Targeted Oncology. 2018 Nov 16
6 citations
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
Peter E. Manley, Tanya M. Trippett, Amy Smith, Margaret E. Macy, Sarah Leary, Jessica Boklan, Kenneth J. Cohen, Stewart Goldman, Lindsay Kilburn, Girish Dhall, Jeanne ...> ;Pediatric Blood & Cancer. 2018 Sep 1
9 citations
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Ketterin...
Lisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, Tanya M. Trippett, Elizabeth Klein, Nancy A. Kernan, Rachel Kobos, Susan E. Prockop, Andromachi Scaradavou, Peter G....> ;Leukemia & Lymphoma. 2018 Aug 3
18 citations
Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia.
Max S. Topp, M Stelljes, Gerhard Zugmaier, Phillip Barnette, Leonard T. Heffner, Tanya M. Trippett, Johannes Duell, Ralf C. Bargou, Chris Holland, Jonathan Benjamin, M...> ;Leukemia. 2018 Feb 1
95 citations
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.
Ester Mejstrikova, Ondrej Hrusak, Michael J. Borowitz, James A. Whitlock, Benoit Brethon, Tanya M. Trippett, G. Zugmaier, Lia Gore, A von Stackelberg, Francesco Locatelli> ;Blood Cancer Journal. 2017 Dec 20
21 citations
Clinical Outcome and Prognosis of Young Patients with Mycosis Fungoides.
Pooja Virmani, Laura E. Levin, Patricia L. Myskowski, Eileen S. Flores, Michael A. Marchetti, Anna Skripnik Lucas, Melissa Pulitzer, Steven M. Horwitz, Tanya M. Trippe...> ;Pediatric Dermatology. 2017 Aug 14
55 citations
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or my...
Todd Cooper, Edward Allan R. Sison, Sharyn D. Baker, Lie Li, Amina Ahmed, Tanya M. Trippett, Lia Gore, Margaret E. Macy, Aru Narendran, Keith J. August, Michael J. Abs...> ;Pediatric Blood & Cancer. 2017 Aug 1
35 citations
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
Oren J. Becher, Nathan E. Millard, Shakeel Modak, Brian H. Kushner, Sofia Haque, Ivan Spasojevic, Tanya M. Trippett, Stephen Gilheeney, Yasmin Khakoo, David Lyden, Kev...> ;Plos One. 2017 Jun 5
13 citations
A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high‐grade astrocytomas: A Pediatric Oncology ...
Margaret E. Macy, Mark W. Kieran, Susan N. Chi, Kenneth J. Cohen, Tobey J. MacDonald, Amy Smith, Michael Etzl, Michele C. Kuei, Andrew M. Donson, Lia Gore, Jennifer Di...> ;Pediatric Blood & Cancer. 2017 May 24
Join now to see all

Press Mentions

$Article on Anti-Tumor Activity of PV-10 Against Relapsed and Refractory Neuroblastoma Published in OncoTargets and Therapy$
Article on Anti-Tumor Activity of PV-10 Against Relapsed and Refractory Neuroblastoma Published in OncoTargets and TherapyFebruary 19th, 2019
Paediatric Cancer Centre for GhanaMarch 30th, 2017
First International Paediatric Cancer Centre for GhanaMarch 29th, 2017
Join now to see all